01 · What is established

The signal that has earned confidence.

  • Modern obesity medications can produce weight loss on a scale that changes food intake, body composition, and the consumer experience of eating.
  • Large energy deficits increase the relevance of protein adequacy, micronutrient density, gastrointestinal tolerability, and preservation of lean mass.
  • Nutrition support must distinguish treatment of obesity from treatment of the nutritional consequences of weight loss.

02 · What remains unsettled

The uncertainty is part of the answer.

  • Which nutrition strategies improve outcomes for specific molecules, doses, and patient populations.
  • How recommendations should change across initiation, maintenance, discontinuation, and weight regain.
  • Where food, supplement, and clinical-service innovation can help without outrunning the evidence.

03 · What this changes

From scientific landscape to decision architecture.

Berkwood helps organizations map the evidence by claim, molecule, outcome, and time horizon, then build research priorities and stakeholder language that make uncertainty visible rather than burying it.

Selected work

Read into the evidence.